本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Olema Pharmaceuticals, Inc.

10.91
+0.48004.60%
成交量:79.99萬
成交額:872.84萬
市值:9.51億
市盈率:-5.12
高:11.02
開:10.60
低:10.60
收:10.43
52周最高:36.26
52周最低:5.36
股本:8,715.70萬
流通股本:7,188.81萬
量比:0.76
換手率:1.11%
股息:- -
股息率:- -
每股收益(TTM):-2.1289
每股收益(LYR):-1.8700
淨資產收益率:-52.74%
總資產收益率:-31.82%
市淨率:2.21
市盈率(LYR):-5.83

資料載入中...

2024/06/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/04

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/15

重要事件披露

Form 8-K - Current report
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/28

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/11

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/11

年度報告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/15

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/08

SEC問詢函

Form CORRESP - Correspondence
2024/02/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/01/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities